List of Excipients in API aspirin and dipyridamole extended release
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing aspirin and dipyridamole extended release
Detailed excipient profiles for aspirin and dipyridamole extended release
Excipient focus: ACACIA
aspirin and dipyridamole extended release drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
aspirin and dipyridamole extended release drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
aspirin and dipyridamole extended release drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
aspirin and dipyridamole extended release drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
aspirin and dipyridamole extended release drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSES
aspirin and dipyridamole extended release drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
aspirin and dipyridamole extended release drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
aspirin and dipyridamole extended release drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
aspirin and dipyridamole extended release drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
aspirin and dipyridamole extended release drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE PHTHALATE
aspirin and dipyridamole extended release drug variants containing HYPROMELLOSE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing HYPROMELLOSE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
aspirin and dipyridamole extended release drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
aspirin and dipyridamole extended release drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
aspirin and dipyridamole extended release drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
aspirin and dipyridamole extended release drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
aspirin and dipyridamole extended release drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
aspirin and dipyridamole extended release drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
aspirin and dipyridamole extended release drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
aspirin and dipyridamole extended release drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
aspirin and dipyridamole extended release drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
aspirin and dipyridamole extended release drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
aspirin and dipyridamole extended release drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
aspirin and dipyridamole extended release drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
aspirin and dipyridamole extended release drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
aspirin and dipyridamole extended release drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
aspirin and dipyridamole extended release drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
aspirin and dipyridamole extended release drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
aspirin and dipyridamole extended release drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
